about
Tobacco use and cancer causation: association by tumour typeIsolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladderTumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamilyTranscriptional regulation of BRCA1 expression by a metabolic switchRapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cellsFHL2, a novel tissue-specific coactivator of the androgen receptorDetection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevanceAmplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC)PCGEM1, a prostate-specific gene, is overexpressed in prostate cancerIncreased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinomaStable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cellsTherapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis.Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.BAG1L enhances trans-activation function of the vitamin D receptorWnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomasLoss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancerDown-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissuesUridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinomaLinking beta-catenin to androgen-signaling pathwayInducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesisPemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neckDecision analysis for the cost-effective management of recurrent colorectal cancerPancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditionsBortezomib resistance can be reversed by induced expression of plasma cell maturation markers in a mouse in vitro model of multiple myelomaGenetic variation and adaptation in Africa: implications for human evolution and diseaseCXC motif chemokine receptor 4 gene polymorphism and cancer risk.Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.Cancer of the male breast.Prostate cancer immunotherapy at the dawn of the new millennium.Male breast carcinoma and the use of MRICharacterization of novel synthesized small molecular compounds against non-small cell lung cancer.Targeted nanoagents for the detection of cancersPost-operative imaging of soft tissue sarcomasIntracranial metastases: spectrum of MR imaging findings.Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report.The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995.New approaches to the understanding of the molecular basis of oral cancer.Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting.Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer
P2860
Q22250963-841526E5-BA51-4DD8-BE0A-697AB25CF5A5Q24291159-3428AC7D-BDB1-49C8-80ED-D4ECFC76DDDFQ24291648-3170E7CF-8E0F-40FB-81F7-CAAD72CB0D03Q24307973-02F29AF7-C84A-4CC4-B987-D02177789591Q24554359-6AC1B83A-1895-4452-BC0D-CA7AC64153D1Q24601620-F87A48C9-BAE9-4BEF-9969-1CB4A6E2FEA2Q24646761-34F24021-272C-49B5-94B8-179DE97EB4F3Q24650685-3500695E-593A-4386-8FBF-8717AEA7ADF8Q24682755-68636E2D-5839-45D7-B6AF-3C566A56FEB2Q24685955-5BB7D4F6-D0C5-4106-88FC-1BFE6D045370Q24795887-13A985CA-D585-47FC-A052-7FB07329E471Q24799697-9FF86829-34FC-455A-9CB9-0D44364174B7Q24801047-ABC06837-7F86-4552-84ED-C729B29EC6B7Q24811949-C90840F8-AEA0-411D-B409-0164DD306B38Q28145102-753EC837-A477-45CB-AEC3-969591DCF102Q28202829-630E7FED-470E-4FDB-8A30-9E098525C895Q28211530-92141CC4-0A09-4DAC-8CB6-295CA1812B66Q28214483-2E2EB770-B6A0-4AEF-B16C-EB37EDE048B7Q28214484-FA39186E-FC39-43D0-A9FB-1C098B77B657Q28215632-BAF7A405-2900-4E38-91E5-FA66CD95EAF3Q28302215-A4F12053-E77B-4276-A8BB-616C761A2FEBQ28347912-4F3D0D4D-E503-4F17-8F59-8398A6EF0BB4Q28354061-7C03E607-66AC-43EE-9BCF-6F4B03ED3307Q28361966-73525C06-D39C-400B-873C-B6E913B0798CQ28534703-4F706818-3A46-4EB4-9BB7-CD8449175BB1Q28657760-80B1BA1E-4D18-4128-9AAC-3F70EE6C8885Q30240169-7B47B873-873E-496D-A69A-871D98C4C882Q30304937-F5664946-00FE-4154-BF9A-C6C5A6629C9AQ30306758-65D388F1-672F-4313-8F88-F3EFDCD2443AQ30327421-A538EBF5-3583-457B-A93F-BBD3FB48E6D0Q30381404-51D916AF-5F3B-44E1-A9DD-B5D47B7F9C43Q30429640-B7EF627F-3E91-4ED0-8A9F-5A7051B2AC15Q30472641-7114D0E9-6C08-4564-92B4-D367696CA6F0Q30483084-6416887A-AB5A-4EE4-93C1-5D22E0F5BA65Q30574051-3173F50B-2EEB-450D-805A-51C780CFC478Q30583610-B2883BB2-159C-40C2-B5B5-295A0DD3575EQ30585313-6E999BAA-05B5-4724-B562-B5CF65A2B952Q30662103-A6647BD3-474E-486F-BC02-DEEBC7447D7BQ30662784-74747238-FC30-4983-88FD-BEA2FB1EF653Q30763413-5AB2563D-988C-43E4-9C75-6B7B5FB57794
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Cancer statistics, 1999.
@en
type
label
Cancer statistics, 1999.
@en
prefLabel
Cancer statistics, 1999.
@en
P2093
P356
P1433
P1476
Cancer statistics, 1999.
@en
P2093
P304
P356
10.3322/CANJCLIN.49.1.8
P407
P577
1999-01-01T00:00:00Z